Screening endoscopy in patients with head and neck neoplasia: a pilot study
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S417
DOI: 10.1055/s-0044-1783744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von J. P. Afonso und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Patients with head and neck neoplasia (HNN) are at an increased risk of synchronous gastro-esophageal neoplasia (GEN) due to shared risk factors such as smoking, alcohol consumption, and HPV infection. Several scientific societies recommend screening HNN patients for synchronous esophageal neoplasms. Nevertheless, particularly in Western centers, few studies evaluated the impact of an organized screening program.
Methods
Prospective study that evaluated an organized GEN screening program in HNN patients diagnosed between 01/06/2020 and 31/12/2022, in a tertiary reference hospital. Patients were proposed to do an upper gastrointestinal endoscopy (UGE) with narrow-band imaging (NBI) and/or Lugol chromoendoscopy.
Results
We evaluated 34 patients, 82.4% male, with a median age of 64.5 (IQR: 57,5-70) years. 82.4% had a history of tobacco use, and 35.3% presented active alcohol consumption. The most common primary HNN sites were the larynx (50.0%) and the tonsil (14.7%), and the most frequent histological type was squamous cell carcinoma (SCC) (88.2%). The median time between HNN and UGE was 4.5 (IQR: 1.25-10) months, and 91.2% of the patients had already started treatment for HNN. The prevalence of synchronous GEN was 14.7% (Esophageal SCC n=4; Cardia adenocarcinoma n=1). One patient underwent ESD of two synchronous SCC (SCC pT1b), with adjuvant radiotherapy, other (T1/T2N0M0) underwent chemotherapy and radiotherapy, and two patients are waiting ESD. The patient with cardia adenocarcinoma underwent ESD (pT1b with lymphatic permeation) and total gastrectomy, with no evidence of residual lesion. All patients with synchronous GEN remain alive in the follow-up.
Conclusions
In our study the prevalence of synchronous GEN in HNN patients was significant and most lesions were detected in an early stage, still amenable for endoscopic resection. This study showed that the implementation of this screening strategy may potentially lead to a better prognosis for these patients and its cost-efficacy should be evaluated. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Afonso, J. P., Rui, M., Santos-Antunes, J., Margarida, M., & Guilherme, M. (2024). Screening endoscopy in patients with head and neck neoplasia: a pilot study. Endoscopy, 56(S 02 S 02), S417. https://doi.org/10.1055/s-0044-1783744
Vancouver
Afonso JP, Rui M, Santos-Antunes J, Margarida M, Guilherme M. Screening endoscopy in patients with head and neck neoplasia: a pilot study. Endoscopy. 2024;56(S 02 S 02):S417. doi:10.1055/s-0044-1783744
BibTeX
@article{Afonso2024,
author = {Afonso, J. P. and Rui, M. and Santos-Antunes, J. and Margarida, M. and Guilherme, M.},
title = {Screening endoscopy in patients with head and neck neoplasia: a pilot study},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S417},
doi = {10.1055/s-0044-1783744}
}
EUVIMED